3B BlackBio Dx completed the acquisition of Coris Bioconcept from Avacta Group.

3B BlackBio Dx, a biotechnology company, completed the acquisition of Coris Bioconcept, a company that develops, manufactures, and markets rapid diagnostic test kits, from Avacta Group, a biotechnology company that focuses on the development and commercialization of innovative cancer therapies and diagnostics. Financial terms were not disclosed.